<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01748006</url>
  </required_header>
  <id_info>
    <org_study_id>H-1-2012-019</org_study_id>
    <nct_id>NCT01748006</nct_id>
  </id_info>
  <brief_title>The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure</brief_title>
  <official_title>The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Finn Gustafsson</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The relationship between the activation of the vasopressin system and central hemodynamics in
      heart failure (including right and left heart filling pressures and cardiac output) is not
      clear. The investigators intend to examine the correlation between levels of copeptin and
      vasopressin and the central hemodynamic system in patients with advanced (class III or IV)
      heart failure. The investigators also aim to examine the relationship of selected cardiac
      biomarkers in blood and urine with cardiac filling pressures and cardiac output in patients
      with decompensated heart failure.

      The study population will consist of 30 patients admitted to the Department of Cardiology at
      Copenhagen University Hospital. Only patients for whom the attending cardiologist has already
      decided upon right heart catheterization for clinical/treatment reasons will be recruited for
      the study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The correlation between levels of plasma copeptin and vasopressin with left ventricular filling pressure and cardiac output</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The correlation between levels of plasma copeptin and vasopressin with urine aquaporin-2 concentration</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation between New York Heart Association (NYHA) class and levels of plasma copeptin and vasopressin</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation between biomarkers levels and survival free of transplantation- and left ventricular assist device insertion</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Blood and urine samples</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care therapy for severe decompensated heart failure</intervention_name>
    <arm_group_label>Blood and urine samples</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine analyses
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of 30 patients with heart failure admitted to the
        Department of Cardiology at the Copenhagen University Hospital, Rigshospitalet,Dennmark.
        Only patients who are already referred to right heart catheterization by the attending
        cardiologist will be recruited for the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years

          2. Left ventricular ejection fraction &lt; 40 %

          3. Diagnosed symptomatic heart failure treated with heart failure medications for at
             least 30 days.

          4. Clinical indication for right heart catheterization for clinical/treatment reasons

          5. NYHA-class III-IV

          6. Relevant heart failure treatment as tolerated by the patient

        Exclusion Criteria:

          1. Absence of clinical/treatment indication of right heart catheterization

          2. Syndrome of Inappropriate Secretion of ADH (SIADH)

          3. Recent acute myocardial infarction within the last 30 days

          4. Presence of infection or inflammatory disease

          5. Malignant disease

          6. Pregnancy

          7. Subjects unwilling or unable to provide written consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Finn Gustafsson, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Finn Gustafsson, MD, DMSc</last_name>
    <phone>004535459743</phone>
    <email>finng@dadlnet.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Louise Balling, MD</last_name>
    <phone>004535452142</phone>
    <email>louise.balling@dadlnet.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiology, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Finn Gustafsson, MD, PhD, DMSc</last_name>
      <phone>004535459743</phone>
      <email>finng@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Louise Balling, MD</last_name>
      <phone>004535452142</phone>
      <email>louise.balling@dadlnet.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Finn Gustafsson, MD, PhD, DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2012</study_first_submitted>
  <study_first_submitted_qc>December 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2012</study_first_posted>
  <last_update_submitted>October 26, 2015</last_update_submitted>
  <last_update_submitted_qc>October 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Finn Gustafsson</investigator_full_name>
    <investigator_title>MD, DMSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

